Highlights ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 14:36:35 13/03/2026 GMT			5-day change	1st Jan Change
233.94 ^USD	+0.66%		-7.38%	-2.77%

03-11	Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing	MT
03-11	Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating	MT

Highlights

02-24	Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana	CI
02-11		FA
02-06	ResMed Chief Legal Officer Sells 50 Common Shares Of Firm	MT
02-06	ResMed Director Sells 2,000 Shares	MT
02-02	America's New Gold Rush (and Why It Just Face-Planted)
01-30	Sector Update: Health Care	MT
01-30	Top Premarket Gainers	MT
01-29	ResMed Posts Higher Fiscal Q2 Non-GAAP Earnings, Revenue	MT
01-29	ResMed beats quarterly profit estimates on strong demand for its sleep devices	RE
01-29	ResMed Posts Fiscal Q2 Non-GAAP EPS of $2.81, Revenue of $1.42 Billion	MT
01-29	ResMed Inc. Declares Quarterly Cash Dividend, Payable on March 19, 2026	CI
01-29	ResMed Fiscal Q2 Adjusted Earnings, Revenue Rise	MT
01-29	Earnings Flash (RMD) Resmed Inc. Reports Q2 Revenue $1.42B, vs. FactSet Est of $1.40B	MT
01-29	Earnings Flash (RMD) Resmed Inc. Posts Q2 Adjusted EPS $2.81 per Share, vs. FactSet Est of $2.74	MT
01-29	ResMed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2025	CI
01-28	Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.	CI
01-23	Diary - U.S. Earnings Week Ahead	RE
01-23	Diary - Australia, New Zealand corporate earnings week ahead	RE
12-09	Shares of Resmed Fall After Securing FDA Clearance for a Device Recommending Personalized Comfort Settings	MT
12-08	ResMed Receives FDA Clearance for AI-Powered Device to Personalize Sleep Apnea Therapy	MT
12-08	Resmed, Inc. Receives FDA Clearance for Personalized Therapy Comfort Settings, to Be Marketed as Smart Comfort	CI
11-12		FA
11-11	ResMed Insider Sold Shares Worth $2,000,773, According to a Recent SEC Filing	MT
11-05	ResMed CFO Sells Shares	MT
11-05	ResMed CFO Buys, Sells Shares	MT